Objective To develop new classification criteria for systemic lupus erythematosus ( SLE )
jointly supported by the European League Against Rheumatism ( EULAR ) and the American …

Background— A recent case-control study suggested a benefit of hydroxychloroquine (HCQ)
in lowering the risk of cardiac manifestations of neonatal lupus (cardiac-NL) in pregnancies …

Background— Cardiac manifestations of neonatal lupus include conduction disease and,
rarely, an isolated cardiomyopathy. This study was initiated to determine the mortality and …

Objective Epidemiologic data on systemic lupus erythematosus (SLE) are limited, particularly
for racial/ethnic subpopulations in the US. This meta‐analysis leveraged data from the …

Background Based on the potential involvement of Toll-like receptor (TLR) signalling in the
pathogenesis of neonatal lupus (NL), it was hypothesised that fetal exposure to …

Objective To evaluate seroreactivity and disease flares after COVID‐19 vaccination in a
multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods …

Autoimmune congenital heart block (CHB) is an immune-mediated acquired disease that is
associated with the placental transference of maternal antibodies specific for Ro and La …

Objective The recurrence rate of anti‐SSA/Ro–associated congenital heart block (CHB) is
17%. Sustained reversal of third‐degree block has never been achieved. Based on potential …

Objective The Manhattan Lupus Surveillance Program (MLSP) is a population‐based registry
designed to determine the prevalence of systemic lupus erythematosus (SLE) in 2007 and …

Objective. Identifying the frequency of recurrent cardiac manifestations of neonatal lupus (NL)
in a second child is critical to understanding the pathogenesis of anti-SSA/Ro–mediated …